- Grayscale’s Solana Trust ETF is approved for listing on NYSE Arca, starting October 29, 2025.
- The ETF will offer investors direct exposure to $SOL, including potential staking rewards.
- Solana’s price is currently down 3.2% daily and 6.4% over the past month, despite a recent partial recovery.
- Bitcoin and Ethereum saw significant price increases after spot ETF approvals.
- Solana’s price remains 33.3% below its all-time high of $293.31, but its long-term outlook shows resilience.
Grayscale’s Solana Trust ETF received regulatory approval to list on NYSE Arca and will begin trading on October 29, 2025. This product allows investors direct exposure to Solana (SOL), including its potential staking rewards.
According to a statement from Grayscale, the ETF will use the ticker $GSOL. The company applied earlier this year to convert its Solana Trust into an ETF, following a trend seen with other crypto assets in the market.
Data from CoinGecko shows Solana’s price is down 3.2% on the daily charts, 4.2% over the past 14 days, and 6.4% in the last month. However, SOL’s price rose 6.2% in the previous month and 8.4% since late October 2024.
Other cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH) have experienced price increases after spot ETFs were approved by the SEC. Bitcoin hit multiple all-time highs last year following 11 spot ETF approvals, while Ethereum reached a new all-time high earlier this year supported by increased ETF inflows.
Solana remains 33.3% below its all-time high of $293.31. The market is currently weak, with many major crypto assets facing price corrections. SOL has shown resilience since falling below $9 in 2022 after the FTX collapse. The asset has since reached multiple price peaks and may see further gains as market conditions improve.
Additional developments include plans for Western Union to launch a stablecoin on the Solana Blockchain in 2026, further integrating SOL into mainstream finance.
✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.
